Gender Aspects of the Role of the Metabolic Syndrome as a Risk Factor for Cardiovascular Disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Reaven, 1988, Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diabetes.37.12.1595
Grundy, 1999, Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology, Circulation, 100, 1481, 10.1161/01.CIR.100.13.1481
Balkau, 1999, Comment on the provisional report from the WHO consultation, Diabet Med, 16, 442, 10.1046/j.1464-5491.1999.00059.x
Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet Med, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
Einhorn, 2003, American College of Endocrinology position statement on the insulin resistance syndrome, Endocr Pract, 9, 237, 10.4158/EP.9.S2.5
Regitz-Zagrosek, 2006, Gender differences in the metabolic syndrome and their role for cardiovascular disease, Clin Res Cardiol., 95, 136, 10.1007/s00392-006-0351-5
Grundy, 2004, Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition, Circulation, 109, 433, 10.1161/01.CIR.0000111245.75752.C6
Rathmann, 2003, High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening, Diabetologia, 46, 182, 10.1007/s00125-002-1025-0
Ryden, 2007, Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary, Eur Heart J, 28, 88
Hanefeld, 2003, Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: The Risk Factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes Study, Diabetes Care, 26, 868, 10.2337/diacare.26.3.868
Lorenzo, 2003, The metabolic syndrome as predictor of type 2 diabetes: The San Antonio heart study, Diabetes Care, 26, 3153, 10.2337/diacare.26.11.3153
Alexander, 2003, NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older, Diabetes, 52, 1210, 10.2337/diabetes.52.5.1210
Balkau, 2002, Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome, Diabetes Metab, 28, 364
Ford, 2002, Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey, JAMA, 287, 356, 10.1001/jama.287.3.356
Steinbaum, 2004, The metabolic syndrome: An emerging health epidemic in women, Prog Cardiovasc Dis, 46, 321, 10.1016/j.pcad.2003.08.005
Pannier, 2006, Cardiovascular risk markers associated with the metabolic syndrome in a large French population: The “SYMFONIE” study, Diabetes Metab, 32, 467, 10.1016/S1262-3636(07)70305-1
Csaszar, 2006, Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population, Blood Press, 15, 101, 10.1080/08037050600772284
Lorenzo, 2003, Central adiposity determines prevalence differences of the metabolic syndrome, Obes Res, 11, 1480, 10.1038/oby.2003.198
Tchernof, 2000, Body fat distribution, the menopause transition, and hormone replacement therapy, Diabetes Metab., 26, 12
Gambacciani, 1999, Climacteric modifications in body weight and fat tissue distribution, Climacteric, 2, 37, 10.3109/13697139909025561
Poehlman, 1995, Changes in energy balance and body composition at menopause: A controlled longitudinal study, Ann Intern Med., 123, 673, 10.7326/0003-4819-123-9-199511010-00005
Carr, 2003, The emergence of the metabolic syndrome with menopause, J Clin Endocrinol Metab, 88, 2404, 10.1210/jc.2003-030242
Mayes, 2004, Direct effects of sex steroid hormones on adipose tissues and obesity, Obes Rev, 5, 197, 10.1111/j.1467-789X.2004.00152.x
Wajchenberg, 2000, Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome, Endocr Rev, 21, 697, 10.1210/er.21.6.697
Krotkiewski, 1983, Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution, J Clin Invest, 72, 1150, 10.1172/JCI111040
Pedersen, 2004, Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution, J Clin Endocrinol Metab, 89, 1869, 10.1210/jc.2003-031327
Lonnqvist, 1997, Sex differences in visceral fat lipolysis and metabolic complications of obesity, Arterioscler Thromb Vasc Biol, 17, 1472, 10.1161/01.ATV.17.7.1472
Van Harmelen, 1998, Leptin secretion from subcutaneous and visceral adipose tissue in women, Diabetes, 47, 913, 10.2337/diabetes.47.6.913
Huang, 2004, Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents, Int J Obes Relat Metab Disord, 28, 470, 10.1038/sj.ijo.0802531
Montague, 1997, Depot- and sex-specific differences in human leptin mRNA expression: Implications for the control of regional fat distribution, Diabetes, 46, 342, 10.2337/diabetes.46.3.342
Ryo, 2004, Adiponectin as a biomarker of the metabolic syndrome, Circ J, 68, 975, 10.1253/circj.68.975
Costacou, 2004, The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study, Diabetologia, 48, 41, 10.1007/s00125-004-1597-y
Laughlin, 2000, Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: The Rancho Bernardo Study, J Clin Endocrinol Metab., 85, 645, 10.1210/jc.85.2.645
Bjorntorp, 2000, Metabolic difference between visceral fat and subcutaneous abdominal fat [in French], Diabetes Metab, 26, 10
Valve, 1999, Two polymorphisms in the peroxisome proliferatoractivated receptor-γ gene are associated with severe overweight among obese women, J Clin Endocrinol Metab, 84, 3708, 10.1210/jc.84.10.3708
Regitz-Zagrosek, 2004, Gender aspects in heart failure. Pathophysiology and medical therapy, Arch Mal Coeur Vaiss, 97, 899
Nordmeyer, 2004, Upregulation of myocardial estrogen receptors in human aortic stenosis, Circulation, 110, 3270, 10.1161/01.CIR.0000147610.41984.E8
Peterson, 2004, Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women, Circulation, 109, 2191, 10.1161/01.CIR.0000127959.28627.F8
Thomas, 2005, Cardiovascular mortality in overweight subjects: The key role of associated risk factors, Hypertension, 46, 654, 10.1161/01.HYP.0000184282.51550.00
Knopp, 2005, Gender differences in lipoprotein metabolism and dietary response: Basis in hormonal differences and implications for cardiovascular disease, Curr Atheroscler Rep, 7, 472, 10.1007/s11883-005-0065-6
Assmann, 2002, Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study, Circulation, 105, 310, 10.1161/hc0302.102575
de Aloysio, 1999, The effect of menopause on blood lipid and lipoprotein levels, Atherosclerosis, 147, 147, 10.1016/S0021-9150(99)00315-9
Jensen, 1990, Influence of menopause on serum lipids and lipoproteins, Maturitas, 12, 321, 10.1016/0378-5122(90)90012-U
Wilson, 1998, Prediction of coronary heart disease using risk factor categories, Circulation, 97, 1837, 10.1161/01.CIR.97.18.1837
Assmann, 1992, The importance of triglycerides: Results from the Prospective Cardiovascular Munster (PROCAM) Study, Eur J Epidemiol, 8, 99, 10.1007/BF00145359
Gasse, 2001, Assessing hypertension management in the community: Trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984-1995, J Hum Hypertens, 15, 27, 10.1038/sj.jhh.1001120
Nickenig, 2004, Should angiotensin II receptor blockers and statins be combined?, Circulation, 110, 1013, 10.1161/01.CIR.0000139857.85424.45
Fischer, 2002, Renin angiotensin system and gender differences in the cardiovascular system, Cardiovasc Res, 53, 672, 10.1016/S0008-6363(01)00479-5
Reckelhoff, 2001, Gender differences in the regulation of blood pressure, Hypertension, 37, 1199, 10.1161/01.HYP.37.5.1199
Pechere-Bertschi, 2004, Female sex hormones, salt, and blood pressure regulation, Am J Hypertens, 17, 994, 10.1016/j.amjhyper.2004.08.009
Wang, 2002, Impact of age and sex on plasma natriuretic peptide levels in healthy adults, Am J Cardiol, 90, 254, 10.1016/S0002-9149(02)02464-5
Rahmouni, 2005, Obesity-associated hypertension: New insights into mechanisms, Hypertension, 45, 9, 10.1161/01.HYP.0000151325.83008.b4
Faria, 2002, Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women, Obes Res, 10, 1203, 10.1038/oby.2002.164
Cheurfa, 2004, The Gly482Ser polymorphism in the peroxisome proliferator-activated receptor-γ coactivator-1 gene is associated with hypertension in type 2 diabetic men, Diabetologia, 47, 1980, 10.1007/s00125-004-1567-4
Oberkofler, 2003, Peroxisome proliferator-activated receptor-γ coactivator-1 gene locus: Associations with hypertension in middle-aged men, Hypertension, 41, 368, 10.1161/01.HYP.0000050962.48249.B7
Kuznetsova, 2004, Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion, Circulation, 110, 2644, 10.1161/01.CIR.0000145541.63406.BA
Kannel, 2000, Incidence and epidemiology of heart failure, Heart Fail Rev, 5, 167, 10.1023/A:1009884820941
Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project, Eur Heart J, 24, 987, 10.1016/S0195-668X(03)00114-3
2003, The DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts, Diabetes Care, 26, 61, 10.2337/diacare.26.1.61
Pomerleau, 1999, Relationships of fasting and postload glucose levels to sex and alcohol consumption, Are American Diabetes Association criteria biased against detection of diabetes in women? Diabetes Care, 22, 430
Falkner, 1994, Gender differences in insulin-stimulated glucose utilization among African-Americans, Am J Hypertens, 7, 948, 10.1093/ajh/7.11.948
Travers, 2002, Insulin resistance during puberty and future fat accumulation, J Clin Endocrinol Metab, 87, 3814, 10.1210/jc.87.8.3814
Williams, 2003, Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius, Does sex matter? Diabet Med, 20, 915, 10.1046/j.1464-5491.2003.01059.x
Goldstein, 2002, Insulin resistance as the core defect in type 2 diabetes mellitus, Am J Cardiol, 90, 3G, 10.1016/S0002-9149(02)02553-5
Ehm, 2000, Genomewide search for type 2 diabetes susceptibility genes in four American populations, Am J Hum Genet., 66, 1871, 10.1086/302950
Pan, 1986, Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women, Am J Epidemiol, 123, 504, 10.1093/oxfordjournals.aje.a114266
Barrett-Connor, 1998, Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study, Diabetes Care, 21, 1236, 10.2337/diacare.21.8.1236
Lundberg, 1997, Diabetes as a risk factor for myocardial infarction: Population and gender perspectives, J Intern Med, 241, 485, 10.1111/j.1365-2796.1997.tb00006.x
Barrett-Connor, 1991, Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men The Rancho Bernardo Study, JAMA, 265, 627, 10.1001/jama.1991.03460050081025
Scheidt-Nave, 1991, Sex differences in fasting glycemia as a risk factor for ischemic heart disease death, Am J Epidemiol, 133, 565, 10.1093/oxfordjournals.aje.a115928
Thompson, 1995, Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris, N Engl J Med, 332, 635, 10.1056/NEJM199503093321003
Steinberg, 2000, Type II diabetes abrogates sex differences in endothelial function in premenopausal women, Circulation, 101, 2040, 10.1161/01.CIR.101.17.2040
Huxley, 2006, Excess risk of fatal coronary heart disease associated with diabetes in men and women: Meta-analysis of 37 prospective cohort studies, BMJ, 332, 73, 10.1136/bmj.38678.389583.7C
Azziz, 2002, Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling, J Clin Endocrinol Metab, 87, 4085, 10.1210/jc.2002-021131
Bjorntorp, 1991, Metabolic implications of body fat distribution, Diabetes Care, 14, 1132, 10.2337/diacare.14.12.1132
Moran, 2004, Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome, Best Pract Res Clin Obstet Gynaecol, 18, 719, 10.1016/j.bpobgyn.2004.05.003
Gambineri, 2002, Obesity and the polycystic ovary syndrome, Int J Obes Relat Metab Disord, 26, 883, 10.1038/sj.ijo.0801994
Granger, 2002, Pathophysiology of preeclampsia: Linking placental ischemia/hypoxia with microvascular dysfunction, Microcirculation, 9, 147, 10.1038/sj.mn.7800137
Reckelhoff, 2005, Testosterone supplementation in aging men and women: Possible impact on cardiovascular-renal disease, Am J Physiol Renal Physiol, 289, F941, 10.1152/ajprenal.00034.2005
Neugarten, 2000, Effect of gender on the progression of nondiabetic renal disease: A meta-analysis, J Am Soc Nephrol, 11, 319, 10.1681/ASN.V112319
Silbiger, 2003, The role of gender in the progression of renal disease, Adv Ren Replace Ther, 10, 3, 10.1053/jarr.2003.50001
Kalme, 2005, Sex hormonebinding globulin and insulin-like growth factorbinding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men, J Clin Endocrinol Metab, 90, 1550, 10.1210/jc.2004-0762
Lindstedt, 1991, Low sexhormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-Yr follow-up of population study of women in Gothenburg, Sweden, Diabetes, 40, 123, 10.2337/diabetes.40.1.123
Sundstrom, 2006, Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: Prospective, population based cohort study, BMJ, 332, 878, 10.1136/bmj.38766.624097.1F
Kahn, 2005, The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, 28, 2289, 10.2337/diacare.28.9.2289
Sundstrom, 2006, Risk associated with the metabolic syndrome versus the sum of its individual components, Diabetes Care, 29, 1673, 10.2337/dc06-0664
Stern, 2004, Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease [published correction appears in Diabetes Care, 2005;28:238]? Diabetes Care, 27, 2676
Mogelvang, 2006, A simple linear model for the effect of changes in metabolic risk factors on coronary heart disease, J Intern Med, 259, 561, 10.1111/j.1365-2796.2006.01634.x
Wannamethee, 2005, Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus, Arch Intern Med, 165, 2644, 10.1001/archinte.165.22.2644
Isomaa, 2001, Cardiovascular morbidity and mortality associated with the metabolic syndrome, Diabetes Care, 24, 683, 10.2337/diacare.24.4.683
Lakka, 2002, The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men, JAMA, 288, 2709, 10.1001/jama.288.21.2709
Marroquin, 2004, Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: A report from the Women's Ischemia Syndrome Evaluation, Circulation, 109, 714, 10.1161/01.CIR.0000115517.26897.A7
Gibbons, 2002, ACC/AHA 2002 guideline update for exercise testing: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines), Circulation, 106, 1883, 10.1161/01.CIR.0000034670.06526.15